Repository logo
 
No Thumbnail Available
Publication

IR780-loaded TPGS-TOS micelles for breast cancer photodynamic therapy

Use this identifier to reference this record.
Name:Description:Size:Format: 
2017 Pais-silva EJPB.pdf2.29 MBAdobe PDF Download

Advisor(s)

Abstract(s)

IR780 iodide is a near-infrared (NIR) dye with a huge potential for cancer imaging and phototherapy. However, its biomedical application is strongly impaired by its lipophilic character. Herein, amphiphilic micelles based on d-α-tocopheryl polyethylene glycol succinate (TPGS) and d-α-tocopheryl succinate (TOS), two vitamin E derivatives with intrinsic anticancer activity, are explored to load IR780. IR780-loaded micelles with suitable sizes are obtained by using specific TPGS and TOS weight feed ratios during micelles formulation and these are able to encapsulate IR780 with high efficiency. In in vitro assays, the IR780-loaded micelles induce a cytotoxic effect in cancer cells upon exposure to NIR irradiation through the generation of reactive oxygen species (photodynamic therapy). This effective ablation of cancer cells is achieved using an ultra-low IR780 concentration. Moreover, IR780-loaded micelles also have the ability to act as photothermal and imaging agents, which widens their therapeutic and diagnostic potential. Overall, TPGS-TOS micelles are promising nanoplatforms for IR780-mediated cancer phototherapy and imaging.

Description

Keywords

Breast cancer Photodynamic therapy Photothermal therapy TPGS-TOS micelles IR780 iodide

Pedagogical Context

Citation

Pais-Silva, C., de Melo-Diogo e Correia, I. J (2017) “IR780-loaded TPGS-TOS micelles for breast cancer photodynamic therapy.” European Journal of Pharmaceutics and Biopharmaceutics, Vol.113, pp.108-117

Organizational Units

Journal Issue

Publisher

Elsevier

CC License

Altmetrics